Management of amlodipine influenced gingival overgrowth

This case series presents diagnosis and management of amlodipine-induced gingival hyperplasia amlodipine-induced gingival enlargement was diagnosed and managed by . Gingival overgrowth influenced by amlodipine usually begins at the interdental papilla, which occurs within 6 months of taking medications at a dose of 10mg/day. Although amlodipine is considered a safe drug, it may induce gingival overgrowth in some individualscase presentation: a rare case of amlodipine-induced gingival overgrowth in a 60-year-old indian woman who was on amlodipine for 3 years and subsequent periodontal management of the overgrowth is reported here. Gingival enlargement associated with nifedipine was first reported in the early 1980s and was soon also described with diltiazem and verapamil and in cases with amlodipine and felodipine [4–6] the possible hypothesis to explain this overgrowth is that the fibroblasts contain strongly sulfated mucopolysaccharides that are precursors of ground .

A case of gingival hyperplasia caused by felodipine amlodipine induced gingival overgrowth j clin periodontol 21:281-283, 1994 periodontal management of . Gingival overgrowth (go) is one of the most important clinical features of gingival pathology amlodipine is a comparatively new iii generation calcium channels blocker, used for management of cardiovascular disorders. Nonsurgical management of amlodipine induced gingival enlargement – a case report periodontal management of gingival overgrowth in the heart transplant . The amlodipine influenced gingival overgrowth in this case completely resolved when the patient was switched to beta adrenergic blocker (atenolol) followed by surgical excision of the overgrowth another factor contributing to the excellent response to the therapy is the patient compliance in maintaining the oral hygiene.

This report discusses the importance of conservative approach (scaling and root planning along with drug replacement) in the management of a case of amlodipine influenced gingival enlargement the need for extensive surgery was decreased after this approach. Management of drug-induced gingival overgrowth associated with the use of amlodipine- a case report - free download as pdf file (pdf), text file (txt) or read online for free. Phenytoin-induced gingival overgrowth: a case report and gingival inflammation influence the relationship between et alamlodipine induced gingival overgrowth . Prescribed for the management of cardiovascular disorders it is of concern and promoting gingival overgrowth with amlodipine is much lower with very few cases. Drug-induced gingival overgrowth, soyoral y amlodipine-induced gingival hyperplasia in chronic renal failure: a case report management of .

Bles and pre-existing gingival inflammation all influence the response of gingiva to these medications (6) they like amlodipine, gingiva, gingival, overgrowth . The management of drug induced gingival overgrowth is a challenge for the periodontist, mainly due to decreased knowledge of its pathogenesis, difficulties in . Abstract amlodipine is a calcium channel blocker used in the management of angina and hypertension we report 3 cases of gingival overgrowth in adult dentate patients .

Management of amlodipine influenced gingival overgrowth

Amlodipine is a third generation dihydropyridine calcium channel blocker that is frequently used in therapy of hypertension among many side effects, amlodipine has been found associated with gingival overgrowth (go) which usually occurs within the first three months of starting therapy at a dose of . Amlodipine is one of the drugs known to have shown gingival enlargement as its side effect though there are only a few reported cases it is the newer generation channel blockers which are used for treatment of cardiovascular diseases like. Management of amlodipine-induced gingival enlargement: series of three cases amit kumar srivastava , debabrata kundu , prasanta bandyopadhyay , asit kumar pal journal of indian society of periodontology.

Abstract abstract amlodipine is a calcium channel blocker used in the management of angina and hypertension we report 3 cases of gingival overgrowth in adult dentate patients associated with chronic usage of this drug. In this article, a case of amlodipine induced gingival overgrowth has been presented which was managed with the conservative approach the treatment aspect included phase-1 therapy, substitution of the drug, and the maintenance and supportive therapy resulting in excellent clinical outcome. Amlodipine induced gingival overgrowth was first reported by seymour there have been only few reported associations of gingival overgrowth with this drug.

The management of gingival overgrowth seems to be directed at controlling gingival inflammation through a good oral hygiene regimen however in severe cases, surgical excision is the most preferred method. Gingival enlargement or gingival overgrowth (go) is one of the most important clinical features of gingival pathology 1 its etiology is multifactorial and is associated with inflammatory changes in the gingiva. Amlodipine-induced gingival overgrowth in a patient with uncontrolled type 2 diabetes mellitus with hypercholesterolemia: a case report nif-influenced gingival .

management of amlodipine influenced gingival overgrowth Clinical features of gingival pathology amlodipine is a  the first step in drug-induced gingival overgrowth management should be drug substitution (with another. management of amlodipine influenced gingival overgrowth Clinical features of gingival pathology amlodipine is a  the first step in drug-induced gingival overgrowth management should be drug substitution (with another. management of amlodipine influenced gingival overgrowth Clinical features of gingival pathology amlodipine is a  the first step in drug-induced gingival overgrowth management should be drug substitution (with another.
Management of amlodipine influenced gingival overgrowth
Rated 5/5 based on 19 review

2018.